ASX:SHA
ASX:SHAConstruction

ASX Penny Stocks To Watch In September 2025

In the last week, the Australian market has been flat, but it is up 9.5% over the past year with earnings expected to grow by 11% per annum in the coming years. The term 'penny stocks' might feel like a relic of past market eras, but their potential remains significant, particularly when these smaller or newer companies are backed by strong financials. In this context, we'll explore several penny stocks that stand out for their financial strength and offer intriguing opportunities for...
ASX:VGN
ASX:VGNAirlines

Virgin Australia Stock Faces Uncertainty After Recent Share Price Dip and Mixed Valuation Signals

If you are on the fence about what to do with Virgin Australia Holdings stock, you are not alone. Many investors are wondering whether this is the right time to jump in, add to their position, or take some profits. After all, with the stock closing at $3.22 and showing a mixed track record in recent weeks, it is a natural moment for a closer look. Over the past week, Virgin Australia has slipped by 4.2%. Looking at the past month, it has managed to gain 1.6%. Year-to-date, returns have...
ASX:LTR
ASX:LTRMetals and Mining

Will Liontown Resources' (ASX:LTR) Fresh Capital Boost Offset Uncertainty Around Leadership Transition?

Earlier this month, Liontown Resources completed a follow-on equity offering, raising A$56 million to support its expansion and operational improvement plans, while also announcing the departure of its CFO. This combination of fresh capital and executive changes introduces both the potential for accelerated project investment and some new questions around leadership continuity. We'll explore how the infusion of new capital, alongside executive turnover, could affect Liontown's outlook and...
ASX:BOE
ASX:BOEOil and Gas

Is Boss Energy's (ASX:BOE) Operational Review a Strategic Reset or Just Business as Usual?

Boss Energy Limited has initiated a comprehensive operational review of its Honeymoon uranium project in South Australia, focusing on assessing production capacity, mineralisation continuity, and leachability, with expert input and accelerated drilling underway since late July 2025. This proactive review signals management’s commitment to rigorously reassessing project assumptions laid out in the 2021 enhanced feasibility study, addressing market concerns about production challenges. With...
ASX:HDN
ASX:HDNRetail REITs

HomeCo Daily Needs REIT (ASX:HDN): Exploring Whether Current Valuation Reflects Steady Growth and Investor Sentiment

If you have been watching HomeCo Daily Needs REIT (ASX:HDN), a glance at the recent share price movement might catch your eye and have you wondering if now is the right time to make a move. With no single headline-grabbing news to spark the interest, the momentum in HDN’s trading session seems to be driven more by investor sentiment and ongoing portfolio performance. For those mulling over whether to hold, buy, or sell, it is a classic moment to pause and ask what is really moving this stock...
ASX:NST
ASX:NSTMetals and Mining

Does Northern Star Resources' (ASX:NST) Dividend Reinvestment Plan Update Hint at a Strategic Shift?

Northern Star Resources recently updated its announcement regarding its dividend distribution for the six months ending June 30, 2025, to include the price for its Dividend Reinvestment Plan, with a record date of September 3, 2025. This move reflects an ongoing commitment by the company to deliver consistent shareholder returns and could influence future investment preferences among existing and prospective shareholders. We'll look at how the latest Dividend Reinvestment Plan pricing update...
ASX:QAN
ASX:QANAirlines

Does the Recent CEO Transition Signal Opportunity in Qantas Shares for 2025?

If you’ve been mulling over whether to buy, sell, or simply sit tight with your Qantas Airways stock, you’re not alone. The market world has been buzzing about Australian airlines lately, and Qantas is right at the center of attention. It hasn’t all been smooth sailing in recent weeks. The share price has dipped 3.7% over the past seven days and is down 1.9% for the month. Still, zoom out and you’ll spot something eye-catching: a 69.5% gain over the past year, with a 194.7% return across five...
ASX:EVN
ASX:EVNMetals and Mining

Evolution Mining (ASX:EVN): Evaluating Valuation After Latest Dividend Reinvestment Plan Update

Evolution Mining (ASX:EVN) has caught attention with its latest update on the Dividend Reinvestment Plan for the fiscal year ending June 30, 2025. The company confirmed both the DRP price, set at $8.73 per share, and a strong shareholder participation rate of 55.65%, resulting in over 16 million new shares issued. For current and prospective investors, this offers clear insight into Evolution’s capital management approach and could influence your view on the company’s financial...
ASX:SHA
ASX:SHAConstruction

SHAPE Australia (ASX:SHA): Assessing Valuation After Strategic Expansion and Double-Digit Growth

SHAPE Australia (ASX:SHA) is catching the attention of investors thanks to a transformation that goes well beyond the typical paint-and-carpets office refit. The company has pushed hard into sectors like modular construction, defence, education, and health, successfully reshaping both what it builds and how markets perceive its future. With double-digit revenue and profit growth alongside major new project wins, it is no surprise the stock is starting to get more airtime in conversations...
ASX:AUB
ASX:AUBInsurance

Should You Reassess AUB Group After Recent Share Price Pullback?

Thinking of what to do with AUB Group stock? You are not alone. Investors keeping an eye on this fast-growing insurance broker have recently had a bit of a rollercoaster experience. After climbing steadily over the past year with a 16.4% gain, and an impressive 141.8% return over five years, the share price has paused for breath. It is down 4.1% over the last week but still up 2.1% for the past month and 9.3% year-to-date. These movements are catching plenty of attention, especially as...
ASX:SGLLV
ASX:SGLLVFood

Assessing SunRice (ASX:SGLLV)’s Valuation Following Board Renewal and Global Growth Strategy

Thinking about what to do next with Ricegrowers (ASX:SGLLV)? You are not alone. The recent news that Rachel Kelly will be stepping in as a Grower Director has drawn fresh attention to the company, as investors weigh what this leadership renewal may mean for its future. This is not just routine board news. It seems to fit neatly into a bigger narrative of strategic change that has already been gathering steam. Ricegrowers has enjoyed an impressive run, with shares climbing an eye-catching 89%...
ASX:RSG
ASX:RSGMetals and Mining

Why Resolute Mining (ASX:RSG) Is Up 26.4% After Major Doropo Gold Resource Upgrade – And What's Next

Earlier this month, Resolute Mining Limited announced a 28% increase in its Mineral Resource Estimate for the Doropo Gold Project in Northern Côte d'Ivoire, raising total measured, indicated, and inferred resources to 4.4 million ounces at a grade of 1.19 grams per tonne gold. The update highlights that 84% of these resources are in the higher-confidence Measured and Indicated categories, and most mineralization occurs within 150 meters of surface, indicating substantial near-surface...
ASX:4DX
ASX:4DXHealthcare Services

A Look at 4DMedical (ASX:4DX) Valuation Following Landmark Global Partnerships and Expansion Moves

If you have been following 4DMedical (ASX:4DX), you know the company’s latest run of partnership announcements is catching attention across the market, especially for those weighing their next move in the stock. Over just a few weeks, 4DMedical has inked multi-year deals supporting Australia’s National Lung Cancer Screening Program, launched an initiative in Brazil with a key pharma partner, and rolled out a hospital pilot with Royal Melbourne Hospital. Coming soon after US regulatory wins,...
ASX:BOT
ASX:BOTPharmaceuticals

A Look at Botanix Pharmaceuticals (ASX:BOT) Valuation Following South Korea ECCLOCK Gel Approval

Botanix Pharmaceuticals (ASX:BOT) is on the radar this week after its partner Dongwha Pharm secured a regulatory green light for ECCLOCK gel in South Korea, paving the way for a commercial launch in early 2026. This approval is not just another piece of good news for Botanix. It is a meaningful step in its push to grow outside Australia, with the company poised to collect a share of royalties from future sales. Investors tracking Botanix have been waiting for a sign that the company’s...